Skip to main content
. 2021 Mar 15;11:5945. doi: 10.1038/s41598-021-85399-9

Figure 4.

Figure 4

Functional validation of novel CARMIL2 variants. (A) Western blot analysis of CARMIL2 expression. Anti-FLAG antibody was used for immunoblotting (left panel). FLAG-TRAF6 served as positive control, β-actin as loading control. The expected molecular weight of CARMIL2 WT and variants (considering the 3xFLAG tag) is shown for comparison (right panel). The black arrow points to the position of the mutation inside the protein. The observed band (~ 180 kDa) of WT CARMIL2 does not correspond to the predicted protein size (~ 155 kDa); this is consistent with what previously reported and with The Human Protein Atlas (available from v19.3.proteinatlas.org)1,12. Full-length blots are presented in Supplementary Fig. S2. (B) Immunofluorescence staining of HEK293T cells (left panel) and HCT116 cells (right panel) transfected with wild type CARMIL2 or the indicated variants. The first three columns represent the immunofluorescence images of FLAG tagged CARMIL2 (red), actin (green) and nuclei (light blue). The fourth column is a composite image. In HEK293T cells (left panel) CARMIL2 WT and variant p.C155VfsTer54 display a diffuse cytoplasmic expression pattern, while variants p.E978* and p.D623E exhibit a more granular pattern of expression. In HCT116 cells (right panel) expression pattern of all CARMIL2 isoforms is cytoplasmic, although variant p.D623E signal appeared as puncta structures. Scale bar: 7 µm.